Suppr超能文献

印度班加罗尔宫颈癌的发病率、死亡率和生存率

Incidence, mortality and survival in cancer of the cervix in Bangalore, India.

作者信息

Nandakumar A, Anantha N, Venugopal T C

机构信息

Coordinating Unit, National Cancer Registry Programme of India (Indian Council of Medical Research), Kidwai Memorial Institute of Oncology, Bangalore.

出版信息

Br J Cancer. 1995 Jun;71(6):1348-52. doi: 10.1038/bjc.1995.262.

Abstract

Cancer of the cervix is the most common cancer among women in India, constituting between one-sixth to one-half of all female cancers with an age-adjusted incidence rate ranging from 19.4 to 43.5 per 100,000 in the registries under the National Cancer Registry Programme (NCRP) (Annual Reports, NCRP, ICMR). It has been estimated that 100,000 new cases of cancer of the cervix occur in India every year, and 70% or more of these are Stage III or higher at diagnosis. However, the incidence of cancer of the cervix as suggested in this report appears to be on the decline in Bangalore. Besides incidence and clinical stage at presentation knowledge of survival is essential to complete the picture of establishing baseline indicators to monitor and evaluate cancer control programmes. Survival analysis was carried out in 2121 patients diagnosed during 1982-89 in the population of Bangalore, India. The observed 5 year survival was 34.4% and the relative survival 38.3%. Clinical stage at presentation was the single most important variable in predicting survival. The 5 year observed survival for stage I disease was 63.3%, for stage II 44.0%, for stage III 30.3% and for stage IV 5.7%.

摘要

宫颈癌是印度女性中最常见的癌症,占所有女性癌症的六分之一至二分之一,在国家癌症登记计划(NCRP)(NCRP年度报告,印度医学研究理事会)登记处中,年龄调整发病率为每10万人19.4至43.5例。据估计,印度每年有10万例宫颈癌新发病例,其中70%或更多在诊断时为III期或更高分期。然而,本报告显示,班加罗尔的宫颈癌发病率似乎在下降。除了发病率和就诊时的临床分期外,生存情况的了解对于完善建立监测和评估癌症控制项目的基线指标情况也至关重要。对1982年至1989年期间在印度班加罗尔人群中诊断出的2121例患者进行了生存分析。观察到的5年生存率为34.4%,相对生存率为38.3%。就诊时的临床分期是预测生存的唯一最重要变量。I期疾病的5年观察生存率为63.3%,II期为44.0%,III期为30.3%,IV期为5.7%。

相似文献

引用本文的文献

10
Human papilloma virus vaccines: need to be introduced in India.人乳头瘤病毒疫苗:需要在印度引入。
Hum Vaccin Immunother. 2013 Jan;9(1):97-9. doi: 10.4161/hv.22063. Epub 2012 Oct 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验